Acta Neuropathologica

, Volume 120, Issue 5, pp 633–639

Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies

Original Paper


Lewy bodies (LBs), the pathological hallmark of Lewy body disease (LBD), contain α-synuclein, as well as other proteins. In this study, we examined the relationship of α-synuclein to two rate-limiting enzymes in neurotransmitter synthesis, tyrosine hydroxylase (TH) and choline acetyltransferase (ChAT). Double-labeling immunohistochemistry for α-synuclein and TH revealed TH immunoreactivity within LBs in catecholaminergic neurons in the substantia nigra and locus coeruleus, but not within LBs in cholinergic neurons in the pedunculopontine nucleus and nucleus basalis of Meynert. In contrast, ChAT immunoreactivity within LBs was detected in cholinergic, but not within LBs in catecholaminergic neurons. The amygdala was devoid of TH and ChAT positive LBs, although a few Lewy neurites contained ChAT immunoreactivity. Further analysis revealed two distinct patterns of neurotransmitter immunoreactivity within LBs. One pattern had diffuse co-localization of TH or ChAT with α-synuclein as in cortical-type LBs, while the other had intense TH or ChAT immunoreactivity in the LB core surrounded by a peripheral rim of α-synuclein as in brainstem-type LBs. Levels of both TH and ChAT were higher in brainstem-type LBs than in the cytoplasm of the same neuron or in neurons from the same case devoid of LBs. Given the fact that LB-containing neurons have decreases in cytoplasmic TH and ChAT immunoreactivity, these results suggest LBs may disrupt cholinergic and catecholaminergic neurotransmitter production by sequestration of the rate-limiting enzymes for acetylcholine and catecholamine synthesis.


α-Synuclein Choline acetyltransferase Lewy bodies Locus coeruleus Nucleus basalis of Meynert Pedunculopontine nucleus Substantia nigra Tyrosine hydroxylase 


  1. 1.
    Beach TG, White CL, Hamilton RL et al (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277–288CrossRefPubMedGoogle Scholar
  2. 2.
    Dickson DW, Davies P, Mayeux R et al (1987) Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol 75:8–15CrossRefPubMedGoogle Scholar
  3. 3.
    Gomez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT (2000) alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol 99:352–357CrossRefPubMedGoogle Scholar
  4. 4.
    Kosaka K (1978) Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol 42:127–134CrossRefPubMedGoogle Scholar
  5. 5.
    Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y (1988) Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol 75:345–353CrossRefPubMedGoogle Scholar
  6. 6.
    Leverenz JB, Umar I, Wang Q et al (2007) Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 17:139–145CrossRefPubMedGoogle Scholar
  7. 7.
    Lippa CF, Smith TW, Perry E (1999) Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology. J Neural Transm 106:525–535CrossRefPubMedGoogle Scholar
  8. 8.
    Masliah E, Galasko D, Wiley CA, Hansen LA (1990) Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia. Acta Neuropathol 80:453–458CrossRefPubMedGoogle Scholar
  9. 9.
    Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, Wakabayashi K (2006) Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J Neuropathol Exp Neurol 65:808–815CrossRefPubMedGoogle Scholar
  10. 10.
    Nakano I, Hirano A (1984) Parkinson’s disease: neuron loss in the nucleus basalis without concomitant Alzheimer’s disease. Ann Neurol 15:415–418CrossRefPubMedGoogle Scholar
  11. 11.
    Nakashima S, Ikuta F (1984) Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains. J Neurol Sci 66:91–96CrossRefPubMedGoogle Scholar
  12. 12.
    Perry E, Court J, Goodchild R et al (1998) Clinical neurochemistry: developments in dementia research based on brain bank material. J Neural Transm 105:915–933CrossRefPubMedGoogle Scholar
  13. 13.
    Perry E, Court J, Goodchild R et al (1998) Clinical neurochemistry: developments in dementia research based on brain bank material. J Neural Transm 105:915–933CrossRefPubMedGoogle Scholar
  14. 14.
    Perry EK, McKeith I, Thompson P et al (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson’s disease, and Alzheimer’s disease. Ann N Y Acad Sci 640:197–202PubMedGoogle Scholar
  15. 15.
    Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183–191CrossRefPubMedGoogle Scholar
  16. 16.
    Popescu A, Lippa CF, Lee VM, Trojanowski JQ (2004) Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol 61:1915–1919CrossRefPubMedGoogle Scholar
  17. 17.
    Rinne JO, Ma SY, Lee MS, Collan Y, Roytta M (2008) Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson’s disease is related to disability of the patients. Parkinsonism Relat Disord 14:553–557CrossRefPubMedGoogle Scholar
  18. 18.
    Schmidt ML, Murray J, Lee VM, Hill WD, Wertkin A, Trojanowski JQ (1991) Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 139:53–65PubMedGoogle Scholar
  19. 19.
    Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103:1661–1668CrossRefPubMedGoogle Scholar
  20. 20.
    Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840CrossRefPubMedGoogle Scholar
  21. 21.
    Tiraboschi P, Hansen LA, Alford M et al (2000) Cholinergic dysfunction in diseases with Lewy bodies. Neurology 54:407–411PubMedGoogle Scholar
  22. 22.
    Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79:581–583CrossRefPubMedGoogle Scholar
  23. 23.
    Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13:243–248CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Neuropathology LaboratoryMayo Clinic College of MedicineJacksonvilleUSA

Personalised recommendations